BioLife Solutions (BLFS) Price / earnings — Quarterly & Annual

Screener

Discontinued — last reported Q1 '18

Price / earnings at other companies

Thermo Fisher ScientificTMO

27.4×+4.2×

DanaherDHR

33.7×-7.7×

TEC

Bio-TechneTECH

70.4×+15.8×

RevvityRVTY

40.9×-3.5×

CryoPort, Inc.CYRX

6.7×—

Bio-Rad LaboratoriesBIO

44.6×—

Other financials

Income statement

Revenue$28.5M+21.5%

Gross profit$18.3M+20.0%

Operating income$1.7M+111%

Net income$45.1M+385%

EPS (diluted)$0.91+376%

Balance sheet

Cash & equivalents$24.0M-24.8%

Total debt$15.7M-33.9%

Total equity$420.0M+21.0%

Total assets$447.5M+15.6%

Cash flow

Operating cash flow$6.3M-13.8%

CapEx$1.0M-40.2%

Free cash flow$5.3M-5.7%

Valuation

Market cap$1.65B+63.7%

Enterprise value$1.64B+64.2%

P/S16.1×+3.8×

Profitability

Gross margin67.2%—

Operating margin1.6%—

Net margin-68.7%—

FCF margin-15.9%+18.7pp

Returns & leverage

Return on equity-14.5%-4.7pp

Debt / equity0×0.0×

Current ratio9.7×+5.3×

Where this comes from

Calculated from BioLife Solutions’s reported figures.

market cap/net income=66.2×

Based on the most recent quarter.

The source filing: BioLife Solutions’s 10-K, filed May 15, 2020. Open the filing →

Filed: May 15, 2020, 5:22 PM EDT
Fiscal year: FY2019
Accession: 0001437749-20-011046

FAQ

What does price / earnings mean?: Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.